CO.DON AG operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares CO.DON AG with three other
pharmaceutical manufacturers in Europe:
sales of 7.46 million Euro [US$8.52 million]
of which 72%
was Research & Development Tax Credit),
Biomed Lublin Wytwornia Surowic I Szczepionek SA
(31.40 million Polish New Zlotys [US$8.34 million]
of which 94%
was Plasma Segment), and
(6.80 million Euro [US$7.77 million]
CO.DON AG reported sales of 5.96 million Euro (US$6.82 million)
December of 2017.
increase of 6.5%
versus 2016, when the company's sales were 5.60 million Euro.
Sales at CO.DON AG have increased during each of the previous five years
(and since 2012, sales have increased a total of 122%).